Alembic Pharmaceuticals Limited: Business Overview, Financials & Competitive Analysis
Alembic Pharmaceuticals Limited scores 6/10 on the AskCyborg Cyborg Score (Solid). Steady-growth Indian pharmaceutical player with strong domestic market positioning but limited international differentiation. Alembic demonstrates stable operations as a mid-sized Indian pharma company with established market presence and manufacturing capabilities. However, it faces intense competition from larger peers and regulatory challenges typical in the pharmaceutical sector.
What is Alembic Pharmaceuticals Limited's industry? Alembic Pharmaceuticals Limited (alembicpharma.com) operates in Pharmaceuticals - Generics and Branded Formulations. AskCyborg classifies Alembic Pharmaceuticals Limited under Pharmaceuticals - Generics and Branded Formulations in its company registry.
Alembic Pharmaceuticals is an Indian multinational pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products across multiple therapeutic areas. The company o...
Cyborg Score thesis
Steady-growth Indian pharmaceutical player with strong domestic market positioning but limited international...
Read the full analyst-debate transcript →Get the Latest Alembic Pharmaceuticals Limited Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeAlembic Pharmaceuticals Limited Overview
Pro stress-test →Alembic Pharmaceuticals is an Indian multinational pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products across multiple therapeutic areas. The company operates through both branded and generic formulations, serving domestic and international markets with a significant presence in India, USA, and other emerging markets.
Strategic Profile
Pro stress-test →Alembic competes in the highly competitive generic and branded pharmaceutical space, with strategic advantages in cost-effective manufacturing and established distribution networks in India. The company focuses on high-value therapeutic segments including cardiovascular, anti-diabetic, and gastrointestinal products to differentiate from competitors.
Competitive Landscape
Pro stress-test →Alembic competes with larger Indian pharma companies like Cipla, Aurobindo Pharma, and Cadila Healthcare, as well as international generic manufacturers. The competitive advantage lies in manufacturing efficiency and domestic distribution, though the company faces pricing pressure from competitors with stronger international presence.
Industry Context
Alembic Pharmaceuticals Limited operates in Pharmaceuticals - Generics and Branded Formulations.
Key facts
Founded: 1907 · Headquarters: Vadodara, India · Employees: 2,500+ · Revenue: $250-300M · Market cap: N/A